nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active Uptake of Oxycodone at Both the Blood-Cerebrospinal Fluid Barrier and The Blood-Brain Barrier without Sex Differences: A Rat Microdialysis Study
|
Bällgren, Frida |
|
|
40 |
11 |
p. 2715-2730 |
artikel |
2 |
A Minimal PBPK Model for Plasma and Cerebrospinal Fluid Pharmacokinetics of Trastuzumab after Intracerebroventricular Administration in Patients with HER2-Positive Brain Metastatic Localizations
|
Puszkiel, Alicja |
|
|
40 |
11 |
p. 2687-2697 |
artikel |
3 |
An Update on Potential Molecular Biomarkers of Dietary Phytochemicals Targeting Lung Cancer Interception and Prevention
|
Peter, Rebecca Mary |
|
|
40 |
11 |
p. 2699-2714 |
artikel |
4 |
Application of Pharmacokinetic Modeling to Characterize Hepatobiliary Disposition of Imaging Agents and Alterations due to Liver Injury in Isolated Perfused Rat Livers
|
Jeong, Angela |
|
|
40 |
11 |
p. 2513-2523 |
artikel |
5 |
Discovery of the Next Generation of Non-peptidomimetic Neurolysin Activators with High Blood-Brain Barrier Permeability: a Pharmacokinetics Study in Healthy and Stroke Animals
|
Zhang, Yong |
|
|
40 |
11 |
p. 2747-2758 |
artikel |
6 |
Elucidation of Carboxylesterase Mediated Pharmacokinetic Interactions between Irinotecan and Oroxylin A in Rats via Physiologically Based Pharmacokinetic Modeling
|
Zhang, Jun |
|
|
40 |
11 |
p. 2627-2638 |
artikel |
7 |
Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions
|
Chu, Jessica |
|
|
40 |
11 |
p. 2567-2584 |
artikel |
8 |
Functional Evaluation of P-gp and Bcrp at the Murine Blood-Cerebrospinal Fluid Barrier
|
Sun, Austin |
|
|
40 |
11 |
p. 2667-2675 |
artikel |
9 |
Genome-Wide Association Study for the Genetic Determinants of Thiopurine Methyltransferase Protein Expression in Human Livers and Racial Differences
|
Smith, Logan S. |
|
|
40 |
11 |
p. 2525-2531 |
artikel |
10 |
How Much is Enough? Impact of Efflux Transporters on Drug delivery Leading to Efficacy in the Treatment of Brain Tumors
|
Zhang, Wenjuan |
|
|
40 |
11 |
p. 2731-2746 |
artikel |
11 |
Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney Disease
|
Chang, Shih-Yu |
|
|
40 |
11 |
p. 2597-2606 |
artikel |
12 |
Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis
|
Briggs, Emily |
|
|
40 |
11 |
p. 2653-2666 |
artikel |
13 |
Oligopeptide/Histidine Transporter PHT1 and PHT2 — Function, Regulation, and Pathophysiological Implications Specifically in Immunoregulation
|
Dong, Minlei |
|
|
40 |
11 |
p. 2585-2596 |
artikel |
14 |
Physiological Dynamics in the Upper Gastrointestinal Tract and the Development of Gastrointestinal Absorption Models for the Immediate-Release Oral Dosage Forms in Healthy Adult Human
|
Wang, Kai |
|
|
40 |
11 |
p. 2607-2626 |
artikel |
15 |
Prediction of the Renal Organic Anion Transporter 1 (OAT1)- Mediated Drug Interactions for LY404039, the Active Metabolite of Pomaglumetad Methionil
|
Pak, Y. Anne |
|
|
40 |
11 |
p. 2499-2511 |
artikel |
16 |
Professor David E. Smith: A Fearless Scientist and Devoted Mentor
|
Thompson, Brian |
|
|
40 |
11 |
p. 2493-2497 |
artikel |
17 |
Proton-Coupled Oligopeptide Transport (Slc15) in the Brain: Past and Future Research
|
Xiang, Jianming |
|
|
40 |
11 |
p. 2533-2540 |
artikel |
18 |
The Critical Role of Equilibrative Nucleoside Transporter-2 in Modulating Cerebral Damage and Vascular Dysfunction in Mice with Brain Ischemia-Reperfusion
|
Chiang, Hui-Ling |
|
|
40 |
11 |
p. 2541-2554 |
artikel |
19 |
The Impact of Post-Processing Temperature on PLGA Microparticle Properties
|
Otte, Andrew |
|
|
40 |
11 |
p. 2677-2685 |
artikel |
20 |
Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice
|
Saleh, Mohammed A. A. |
|
|
40 |
11 |
p. 2555-2566 |
artikel |
21 |
Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity
|
Huh, Yeamin |
|
|
40 |
11 |
p. 2639-2651 |
artikel |